Email updates

Keep up to date with the latest news and content from BMC Medical Genetics and BioMed Central.

Open Access Highly Accessed Research article

Multi-exon deletions of the FBN1 gene in Marfan syndrome

Wanguo Liu13, Iris Schrijver14, Thomas Brenn25, Heinz Furthmayr24 and Uta Francke16*

Author Affiliations

1 Howard Hughes Medical Institute and Department of Genetics, Stanford University Medical Center, Stanford, CA, USA

2 Department of Pathology, Stanford University Medical Center, Stanford, CA, USA

3 Current address: Gene Identification Laboratory, Department of Laboratory Medicine, 812 Hilton, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA

4 Current address: Department of Pathology, Stanford University Medical Center, Stanford, CA 94305-5324, USA

5 Current address: Departments of Pathology, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02115-6195, USA

6 Current address: Beckman Center for Molecular and Genetic Medicine, Room B201, 279 Campus Drive, Stanford University School of Medicine, Stanford, CA 94305-5323, USA

For all author emails, please log on.

BMC Medical Genetics 2001, 2:11  doi:10.1186/1471-2350-2-11

Published: 24 October 2001

Abstract

Background

Mutations in the fibrillin -1 gene (FBN1) cause Marfan syndrome (MFS), an autosomal dominant multi-system connective tissue disorder. The 200 different mutations reported in the 235 kb, 65 exon-containing gene include only one family with a genomic multi-exon deletion.

Methods

We used long-range RT-PCR for mutation detection and long-range genomic PCR and DNA sequencing for identification of deletion breakpoints, allele-specific transcript analyses to determine stability of the mutant RNA, and pulse-chase studies to quantitate fibrillin synthesis and extracellular matrix deposition in cultured fibroblasts. Southern blots of genomic DNA were probed with three overlapping fragments covering the FBN1 coding exons

Results

Two novel multi-exon FBN1 deletions were discovered. Identical nucleotide pentamers were found at or near the intronic breakpoints. In a Case with classic MFS, an in-frame deletion of exons 42 and 43 removed the C-terminal 24 amino acids of the 5th LTBP (8-cysteine) domain and the adjacent 25th calcium-binding EGF-like (6-cysteine) domain. The mutant mRNA was stable, but fibrillin synthesis and matrix deposition were significantly reduced. A Case with severe childhood-onset MFS has a de novo deletion of exons 44–46 that removed three EGF-like domains. Fibrillin protein synthesis was normal, but matrix deposition was strikingly reduced. No genomic rearrangements were detected by Southern analysis of 18 unrelated MFS samples negative for FBN1 mutation screening.

Conclusions

Two novel deletion cases expand knowledge of mutational mechanisms and genotype/phenotype correlations of fibrillinopathies. Deletions or mutations affecting an LTBP domain may result in unstable mutant protein cleavage products that interfere with microfibril assembly.